Cargando…

P329: HIGH IMMUNOPROTEASOME ACTIVITY AS NOVEL INDICATOR FOR SENSITIVITY TO BORTEZOMIB-CONTAINING CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS FROM CHILDREN’S ONCOLOGY GROUP TRIAL AALL1231

Detalles Bibliográficos
Autores principales:	Roeten, Margot, van Dijk, Suzanne, van Meerloo, Johan, Kwidama, Zinia, Jenkins, Gaya, Teachey, David, Devidas, Meenakshi, Loh, Mignon, Kaspers, Gertjan, Zweegman, Sonja, Jansen, Gerrit, Horton, Terzah, Cloos, Jacqueline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428354/ http://dx.doi.org/10.1097/01.HS9.0000968228.81299.a0

Ejemplares similares

Pre-Clinical Evaluation of the Proteasome Inhibitor Ixazomib against Bortezomib-Resistant Leukemia Cells and Primary Acute Leukemia Cells
por: Roeten, Margot S.F., et al.
Publicado: (2021)

Interferon-γ-induced upregulation of immunoproteasome subunit assembly overcomes bortezomib resistance in human hematological cell lines
por: Niewerth, Denise, et al.
Publicado: (2014)

(Immuno)proteasomes as therapeutic target in acute leukemia
por: Cloos, Jacqueline, et al.
Publicado: (2017)

Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy
por: Niewerth, Denise, et al.
Publicado: (2016)

Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitors
por: Franke, Niels E., et al.
Publicado: (2016)

Positioning of proteasome inhibitors in therapy of solid malignancies
por: Roeten, Margot S. F., et al.
Publicado: (2017)

COLLABORATION AGREEMENT No. K1231
por: The European Organisation for Nuclear Research, CERN, et al.
Publicado: (2005)

Bortezomib resistance in multiple myeloma is associated with increased serine synthesis
por: Zaal, Esther A., et al.
Publicado: (2017)

Outstanding outcomes in infants with KMT2Agermline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children’s Oncology Group AALL0631 trial
por: Guest, Erin M., et al.
Publicado: (2022)

Harnessing Gene Expression Profiles for the Identification of Ex Vivo Drug Response Genes in Pediatric Acute Myeloid Leukemia
por: Cucchi, David G.J., et al.
Publicado: (2020)

Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study
por: Maese, Luke, et al.
Publicado: (2023)

Gene Expression Profiles Associated with Pediatric Relapsed AML
por: Bachas, Costa, et al.
Publicado: (2015)

Cost comparison by treatment arm and center‐level variations in cost and inpatient days on the phase III high‐risk B acute lymphoblastic leukemia trial AALL0232
por: DiNofia, Amanda M., et al.
Publicado: (2017)

SARS‐CoV‐2 infections in patients enrolled on the Children's Oncology Group standard‐risk B‐cell acute lymphoblastic leukemia trial, AALL1731
por: Elgarten, Caitlin W., et al.
Publicado: (2023)

Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors
por: Verbrugge, Sue Ellen, et al.
Publicado: (2013)

The Function of Immunoproteasomes—An Immunologists’ Perspective
por: van den Eshof, Bart L., et al.
Publicado: (2021)

Phosphoproteomic Characterization of Primary AML Samples and Relevance for Response Toward FLT3-inhibitors
por: Cucchi, David G. J., et al.
Publicado: (2021)

Health Tract No. 329: Writing
Publicado: (1868)

Immunoproteasome Activity in Chronic Lymphocytic Leukemia as a Target of the Immunoproteasome-Selective Inhibitors
por: Besse, Andrej, et al.
Publicado: (2022)

Pharmacodynamic monitoring of (immuno)proteasome inhibition during bortezomib treatment of a critically ill patient with lupus nephritis and myocarditis
por: de Groot, Karina A, et al.
Publicado: (2015)

Emergency preparedness for mass gatherings: Lessons of “12.31” stampede in Shanghai Bund
por: Dong, Yong-He, et al.
Publicado: (2017)

Regulation of Immunoproteasome Function in the Lung
por: Keller, Ilona E., et al.
Publicado: (2015)

Dysfunctional immunoproteasomes in autoinflammatory diseases
por: Arimochi, Hideki, et al.
Publicado: (2016)

On the Role of the Immunoproteasome in Protein Homeostasis
por: Basler, Michael, et al.
Publicado: (2021)

Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children’s Oncology Group phase III study AALL0433
por: Lew, Glen, et al.
Publicado: (2020)

A retrospective analysis of 1,231 patients with anemia after surgical treatment of hyperthyroidism
por: Tu, Ruisha, et al.
Publicado: (2018)

1231. Development of state public health goals for antimicrobial stewardship using local data
por: Biehle, Lauren, et al.
Publicado: (2023)

Immunoproteasome Function in Normal and Malignant Hematopoiesis
por: Tubío-Santamaría, Nuria, et al.
Publicado: (2021)

Immunoproteasome inhibition attenuates experimental psoriasis
por: del Rio Oliva, Marta, et al.
Publicado: (2022)

Production, purification, sequencing and activity spectra of mutacins D-123.1 and F-59.1
por: Nicolas, Guillaume G, et al.
Publicado: (2011)

Common variation at 10p12.31 near MLLT10 influences meningioma risk
por: Dobbins, Sara E, et al.
Publicado: (2011)

1231. VIR-2482: A potent and broadly neutralizing antibody for the prophylaxis of influenza A illness
por: Pizzuto, Matteo Samuele, et al.
Publicado: (2020)

Single incision laparoscopic totally extraperitoneal hernioplasty: lessons learned from 1,231 procedures
por: Lee, Yoo Jung, et al.
Publicado: (2021)

Correction to Lancet Neurol 2022; 21: 329–41
Publicado: (2022)

Pandemic tattoos: A review of 329 #covidtattoo on Instagram
por: Kluger, Nicolas
Publicado: (2022)

FRI329 COVID-19: An Uncommon Cause Of Hypophysitis
por: Medina-Torres, Wilnelia, et al.
Publicado: (2023)

Expression Pattern of Immunoproteasome Subunits in Human Thymus
por: Oh, Kwon Ik, et al.
Publicado: (2009)

Corneal Wound Healing Is Compromised by Immunoproteasome Deficiency
por: Ferrington, Deborah A., et al.
Publicado: (2013)

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
por: Basler, Michael, et al.
Publicado: (2014)

Denervation-Induced Activation of the Standard Proteasome and Immunoproteasome
por: Liu, Haiming M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m030047q7qpkobbdv76m8nqh68